Hi Nielsy,
Your all good mate and it is totally a fair question and welcome to NEU. I am probably one of the less optimistic on this forum as I believe the next move is a capital raise but it could also be a take over or partnership deal... it really is a 50:50 at this point. Either way, their product has shown great potential and should it get through phase 3, it is likely that u have purchased at a very good price irrespective of capital raise or not. The main point is, if their product continues to perform and is applied to other neuro areas, this could be massive but there are some nearish term hurdles first... my 2 cents. Everyone else here is about to say "rubbish, deal is imminent" as the have been for >6 months now... good luck.
Add to My Watchlist
What is My Watchlist?
